Biochemical Alterations in Neonatal Hyperbilirubinemia and Bilirubin Encephalopathy: A Review
1 Department of Pediatrics, Medical College of Georgia, Augusta
This review article discusses some current questions concerning the measurement of bilirubin in the blood of newborn infants and the relationship of these blood parameters to the biochemical defects responsible for bilirubin encephalopathy. A discussion of numerous theories, which have been put forth to explain the specific biochemical mechanism by which bilirubin acts on brain metabolism, demonstrates that presently there is no un- equivocal explanation for the molecular events leading to bilirubin encephalopathy.
Submitted on September 21, 1978Accepted on February 5, 1979
This article has been cited by other articles:
![]() |
E. Hanko Unbound Bilirubin and Risk Assessment in the Jaundiced Newborn: Possibilities and Limitations Pediatrics, February 1, 2006; 117(2): 526 - 527. [Full Text] [PDF] |
||||
![]() |
Y. Yilmaz, G. Alper, G. Kilicoglu, L. Celik, L. Karadeniz, and S. Yilmaz-Degirmenci Magnetic Resonance Imaging Findings in Patients With Severe Neonatal Indirect Hyperbilirubinemia J Child Neurol, June 1, 2001; 16(6): 452 - 455. [Abstract] [PDF] |
||||
![]() |
T. W. R. Hansen Bilirubin in the Brain: Distribution and Effects on Neurophysiological and Neurochemical Processes Clinical Pediatrics, August 1, 1994; 33(8): 452 - 459. [PDF] |
||||







